Acceleron leaders and Westlake jumpstart new IPF biotech
After success with the drug Winrevair, a band of entrepreneurs has found their next challenge in a difficult-to-treat lung disease. On Tuesday, Oorja Bio launched with a $30 million Series A round, all from Westlake ...
Sujay Kango, Oorja Bio CEO May 19, 2026 02:15 PM EDTUpdated 03:19 PM Financing Exclusive: Acceleron leaders and Westlake jumpstart new IPF biotech Lei Lei Wu News Reporter After success with the drug Winrevair, a band of entrepreneurs has found their next challenge in a difficult-to-treat lung disease. On Tuesday, Oorja Bio launched … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that